November 4, 2010

Biosimilars Regulations Being Developed in Both Europe and the United States

The European Medicines Agency (EMA) issued draft guidelines for “similar biological medicinal products containing monoclonal antibodies” on November 26, 2010, requesting public comment by May...



MWZB Newsletter Signup

Confidential/Privileged Information MWZB is pleased that you would like to contact the firm. However, you should be aware that any information, documents and the like submitted in connection with this email message or otherwise via the firm’s website will not be treated as a privileged or confidential attorney/client communication unless and until the relationship is governed by an engagement letter. You are not a client of MWZB in the absence of such an engagement letter. If you understand and accept these terms and wish to proceed, please enter your email address below.

Newsletter Signup